Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement

Area of Science:

• Cardiology
• Immunology
• Transplantation Science

Background:

• Heart transplantation is the gold standard for advanced heart failure.
• Acute and chronic rejection significantly impact transplant outcomes.
• Antibody-mediated rejection (AMR) is a primary driver of graft failure and mortality.

Purpose of the Study:

• To outline current diagnostic strategies for AMR post-heart transplantation.
• To describe emerging therapeutic interventions for managing AMR.
• To provide a contemporary overview of AMR in heart transplant recipients.

Main Methods:

• Review of current literature on AMR diagnosis and treatment.
• Integration of histopathology with molecular diagnostics (e.g., donor-specific antibodies, cell-free DNA, gene expression).
• Analysis of evolving therapeutic targets including complement, costimulation, and cytokines.

Main Results:

• AMR diagnosis is evolving beyond traditional histopathology.
• Novel therapies offer targeted approaches beyond general immunosuppression.
• Improved diagnostic accuracy and targeted therapies are crucial for managing AMR.

Conclusions:

• Contemporary diagnosis of AMR incorporates advanced molecular techniques.
• Novel therapeutic strategies provide new avenues for AMR management.
• Optimizing diagnosis and treatment of AMR is essential for improving heart transplant outcomes.